SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Bridger Management, LLC, et al. – ‘SC 13G’ on 10/20/14 re: Medicines Co/DE

On:  Monday, 10/20/14, at 9:32am ET   ·   Accession #:  895345-14-279   ·   File #:  5-60201

Previous ‘SC 13G’:  ‘SC 13G’ on 9/8/14   ·   Next:  ‘SC 13G’ on 1/23/15   ·   Latest:  ‘SC 13G/A’ on 2/14/22

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

10/20/14  Bridger Management, LLC           SC 13G                 1:76K  Medicines Co/DE                   Fried Fr… Jacobson/NY/FA
          Roberto Mignone

Statement of Beneficial Ownership   —   Schedule 13G
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: SC 13G      Statement of Beneficial Ownership                   HTML     44K 


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 
OMB APPROVAL
OMB Number:3235-0145
Estimated average burden hours per response 14.90
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549
 
SCHEDULE 13G
 
Under the Securities Exchange Act of 1934

 
THE MEDICINES COMPANY
(Name of Issuer)
 
Common Stock, $0.001 par value per share
(Title of Class of Securities)
 
(CUSIP Number)
 

(Date of Event which Requires Filing of this Statement)
 


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

¨ Rule 13d-1(b)
 
x Rule 13d-1(c)
 
¨ Rule 13d-1(d)
 

 
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
 
 
 
 

 
 
 
 

CUSIP No. 584688105
13G
 
 

1
NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
 
Bridger Management LLC
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) o
(b) x
 
3
SEC USE ONLY
 
 
 
4
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Delaware
NUMBER OF
 
SHARES
5
SOLE VOTING POWER
 
 
0
BENEFICIALLY
 
OWNED BY
6
SHARED VOTING POWER
 
3,308,151
EACH
 
REPORTING
7
SOLE DISPOSITIVE POWER
 
0
PERSON
 
WITH
8
SHARED DISPOSITIVE POWER
 
3,308,151
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
3,308,151
10
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
o
 
 
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
 
5.1%
 
12
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
IA
 
 
 
 
 

 
 
 
 
 

CUSIP No. 584688105
13G
 
 

1
NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) o
(b) x
 
3
SEC USE ONLY
 
 
 
 
4
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
United States
NUMBER OF
 
SHARES
5
SOLE VOTING POWER
 
 
 
0
BENEFICIALLY
 
OWNED BY
6
SHARED VOTING POWER
 
 
3,308,151
EACH
 
REPORTING
7
SOLE DISPOSITIVE POWER
 
 
0
PERSON
 
WITH
8
SHARED DISPOSITIVE POWER
 
 
3,308,151
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
3,308,151
10
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
o
 
 
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
 
 
5.1%
 
12
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
IN
 
 
 
 
 

 
 
 
 
 
Item 1(a).                Name of Issuer:  The Medicines Company

Item 1(b).
Address of Issuer’s Principal Executive Offices:
 
8 Sylvan Way, Parsippany, New Jersey 07054


Item 2(a, b, c).
Name of Persons Filing, Address of Principal Business Office, Citizenship:
 
 
Bridger Management, LLC, a Delaware limited liability company, 90 Park Avenue, 40th Floor, New York, NY 10016
Mr. Roberto Mignone (“Mr. Mignone”), 90 Park Avenue, 40th Floor, New York, NY 10016. Mr. Mignone is a United States citizen.
 
Item 2(d).
Title of Class of Securities:  Common Stock, $0.001 par value per share (the “Common Stock”)

Item 2(e).
CUSIP Number: 584688105
 

Item 3.
Not Applicable.

Item 4.
Ownership.

Information with respect to the Reporting Persons’ ownership of the Common Stock as of October 20, 2014 is incorporated by reference to items (5) - (9) and (11) of the cover page of the respective Reporting Person.

Swiftcurrent Offshore Master Ltd., Swiftcurrent Partners L.P., and Bridger Healthcare Ltd. are the owners of record of the Common Stock reported herein.  Each of Swiftcurrent Offshore Master Ltd., Swiftcurrent Partners L.P. and Bridger Healthcare Ltd. has beneficial ownership of less than five percent of the Common Stock.  Bridger Management LLC is the investment adviser to Swiftcurrent Offshore Master Ltd., Swiftcurrent Partners L.P. and Bridger Healthcare Ltd.  Mr. Mignone is the managing member of Bridger Management, LLC.  Each of Bridger Management LLC and Mr. Mignone may be deemed to share beneficial ownership of the Common Stock reported herein.

Item 5.
Ownership of Five Percent or less of a Class:
 
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [  ].

Item 6.
Ownership of More than Five Percent on Behalf of Another Person.
 
See Item 4

Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.
 
Not Applicable.

Item 8.
Identification and Classification of Members of the Group.
 
Not Applicable.

Item 9.
Notice of Dissolution of Group.
 
Not Applicable.

Item 10.
Certification.

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11.
 
[Signature Page Follows:]
 
 
 
 

 
 
SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.


 
 
BRIDGER MANAGEMENT, LLC
 
 
  Roberto Mignone, Managing Member  
 
 
 
 
   /s/ Roberto Mignone  
  Roberto Mignone, Individually  
 
 
 
 

 


Exhibit I:           Joint Filing Statement Pursuant to Rule 13d-1(k)
 

 
 
 

 

Exhibit I
JOINT FILING STATEMENT
PURSUANT TO RULE 13d-1(k)

The undersigned acknowledge and agree that the foregoing statement on Schedule 13G, is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G, shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate.

 

 
 
BRIDGER MANAGEMENT, LLC
 
 
  Roberto Mignone, Managing Member  
 
 
 
 
  /s/ Roberto Mignone  
  Roberto Mignone, Individually  
 
 
 
 

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘SC 13G’ Filing    Date    Other Filings
Filed on:10/20/14
10/8/14
12/31/0510-K,  13F-HR
 List all Filings
Top
Filing Submission 0000895345-14-000279   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Wed., Apr. 24, 4:18:53.1pm ET